K
Karin Ekström
Researcher at Karolinska Institutet
Publications - 4
Citations - 1417
Karin Ekström is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 4, co-authored 4 publications receiving 1347 citations.
Papers
More filters
Journal ArticleDOI
Cancer risk following organ transplantation: a nationwide cohort study in Sweden.
Johanna Adami,H. Gäbel,Bernt Lindelöf,Karin Ekström,B. Rydh,Bengt Glimelius,Anders Ekbom,Hans-Olov Adami,Fredrik Granath +8 more
TL;DR: In conclusion, organ transplantation entails a persistent, about four-fold increased overall cancer risk, and the complex pattern of excess risk at many sites challenges current understanding of oncogenic infections that might become activated by immunologic alterations.
Journal ArticleDOI
Cancer Incidence in a Population-Based Cohort of Individuals Hospitalized With Celiac Disease or Dermatitis Herpetiformis
TL;DR: The relative risks for lymphomas and gastrointestinal cancers in this study are lower (and declining) than in most previous reports, and the overall cancer risk is only moderately increased, and nonelevated during childhood and adolescence.
Journal ArticleDOI
Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives.
Karin Ekström,Henrik Hjalgrim,Lena Brandt,Eva Baecklund,Lars Klareskog,Anders Ekbom,Johan Askling +6 more
TL;DR: There is little to suggest a prominent role for coinherited or common environmental risk factors in malignant lymphomas arising in the context of RA, and lymphomas complicating RA appear to be a direct consequence of the inflammation or its treatment.
Journal ArticleDOI
Childbearing and the risk of leukemia in Sweden
Karin Ekström,Joanne Wuu,Chung-Cheng Hsieh,Chung-Cheng Hsieh,Bengt Glimelius,Bengt Glimelius,Mats Lambe +6 more
TL;DR: If pregnancy-related hormonal or immunological factors have an effect on the development of leukemia, it is minor and confined to the myeloid types, chiefly CML.